China's securities regulator ordered brokerages to freeze new cross-border total return swap positions on June 23, shutting one of the most popular channels for domestic capital to reach overseas equities.
At least four state-owned brokerages, including China International Capital Corp., informed institutional clients late Tuesday that they could no longer add new exposure via cross-border total return swaps, according to people familiar with the matter. The restrictions apply to new positions only — existing holdings can be maintained or reduced but cannot be rotated into different securities.
"The move effectively freezes the pipeline for fresh capital flowing into foreign assets through this derivative channel, though existing positions remain untouched," said a senior executive at one affected brokerage, who declined to be named because the matter is sensitive.
The cross-border OTC derivatives book at Chinese brokerages, which includes TRS products, stood at 825.4 billion yuan ($114.7 billion) as of late November 2023, according to the Securities Association of China. CICC is one of only ten brokerages licensed to offer TRS services, giving it an outsized role in this market. The CSI 300 Index had earlier slid to its lowest level since early 2019, underscoring the pressure regulators face to stem capital outflows during a period of severe market stress.
The suspension represents a significant escalation in Beijing's campaign to control capital leaving the country. Cross-border TRS products had become a pressure valve for sophisticated investors — particularly private equity funds — to gain exposure to US tech stocks and other foreign equities without navigating the cumbersome Qualified Domestic Institutional Investor quota system. The restrictions build on regulatory guidance issued in late 2023 that targeted leveraged derivatives trading, followed by explicit limits in February 2024 on the total amount domestic investors could allocate to swaps.
Why regulators are tightening now
The timing coincides with renewed weakness in Chinese equities and persistent depreciation pressure on the yuan. When domestic markets are underperforming and the currency is under pressure, the incentive for investors to seek returns offshore intensifies. By blocking new TRS positions, regulators remove a key avenue for that capital flight without triggering forced selling of existing positions that could destabilize markets further.
The People's Bank of China has kept the 1-year medium-term lending facility rate at 2.50% since the last 15-basis-point cut in August 2024, while the onshore yuan has weakened past 7.30 against the dollar. The yield gap between 10-year Chinese government bonds and US Treasuries stands at roughly 200 basis points, maintaining the structural incentive for capital to seek higher returns abroad.
What this means for investors
For Chinese private equity funds that relied on TRS structures to build overseas tech exposure, the immediate consequence is a portfolio that can only shrink. Some funds now face a "sell-only, no rotation" constraint, according to a person at a 100-billion-yuan private fund. This could create asymmetric selling pressure on US tech stocks held through these structures if managers need to rebalance or raise cash.
The restrictions may push some demand toward the Stock Connect programs linking Shanghai, Shenzhen and Hong Kong, or toward the limited QDII quotas still available. But neither channel offers the same flexibility as TRS for gaining exposure to non-Hong Kong listed foreign stocks, particularly US-listed technology companies.
The last time Beijing imposed comparable restrictions on a popular cross-border investment channel — the 2017 crackdown on overseas acquisitions and the 2021 tightening of QDII quotas — outflows through formal channels contracted by roughly 30% over the following quarter, according to data from the State Administration of Foreign Exchange. A similar pattern this time would further reduce the already subdued capital outflows from China's onshore financial system.
This article is for informational purposes only and does not constitute investment advice.